Maya H Buch

FcγRIIIA‐158V and rheumatoid arthritis: a confirmation study

John D. Isaacs, Michael J. Green, Philip G. Conaghan, 2003 .

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

Jonathan Kay, Gabriel Maciel, Maxime Dougados, 2013, Annals of the rheumatic diseases.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Tsutomu Takeuchi, René Westhovens, Désirée van der Heijde, 2020, Annals of the Rheumatic Diseases.

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis

Laure Gossec, Sofia Ramiro, Paul Emery, 2014, Annals of the rheumatic diseases.

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

Laure Gossec, Sofia Ramiro, R. Landewé, 2014, Annals of the rheumatic diseases.

Sequential use of biologic therapy in rheumatoid arthritis

M. Buch, Maya H Buch, 2010, Current opinion in rheumatology.